DBS to add 100 wealth bankers in Hong Kong as clients trade more
[HONG KONG] DBS Group Holdings, Singapore's largest lender, is planning to recruit 100 bankers catering to the rich in Hong Kong over the next three years with clients having more appetite to trade.
Clients with at least HK$1 million (S$163,138) in investible assets are becoming more active in the financial markets, prompting the firm to add headcount, Ajay Mathur, DBS' head of Hong Kong consumer banking and wealth management, told the South China Morning Post in an interview. Volatility across assets from equity to bonds and currencies attracted investment demand, Mathur said in the article, which was confirmed by DBS.
DBS's Hong Kong wealth revenue grew 86 per cent in the first quarter from the corresponding period in 2023, according to Mathur.
DBS is also looking to add another wealth management hub in the city next year to offer products including insurance and financial planning services, he said. Its first such local centre opened last year at Queen's Road Central, targeting rich customers from Hong Kong and China. BLOOMBERG
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
12 hours ago
- Business Times
SunMoon Food CEO Zhang Ye boosts interests
[SINGAPORE] Over the four trading sessions from Jun 13 to 18, institutions were net sellers of Singapore stocks, with net institutional outflow of S$42 million following the S$80 million net outflow in the preceding five sessions. This takes the net institutional outflow for the year to Jun 18 to S$1.88 billion. Institutional flows In the four trading sessions, the stocks with the highest net institutional outflow were DBS , Singapore Airlines (SIA), Wilmar International , Singtel , OCBC , Sats , Mapletree Industrial Trust , UOL , Riverstone , and DFI Retail Group . Meanwhile, Keppel , Singapore Exchange (SGX), ST Engineering , CapitaLand Integrated Commercial Trust , Yangzijiang Shipbuilding , Jardine Matheson , Mapletree Logistics Trust , Rex International , Hongkong Land , and Seatrium led the net institutional inflow over the four sessions. From a sector perspective, financial services and consumer non-cyclicals experienced the highest net institutional outflow, while industrials and real estate investment trusts (Reits) had the most net institutional inflow. Singtel leads net institutional inflows in Q2 2025 Institutions were net sellers for much of the second quarter of 2025, but sector flows were mixed, with financial services and Reits seeing the largest outflows, while telecommunications and industrials – led by Singtel, SIA, Keppel, and ST Engineering – recorded notable inflows. From end-2023 to Jun 18, Singtel led net institutional inflows into the local market with S$1.6 billion, while its Straits Times Index weight rose from 6 per cent to 8 per cent. Its total return ranked it as the second-best performer in the Dow Jones Sector Titans Telecommunication Index. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Earlier this month, Gerald Wong, founder of financial advisory platform Beansprout, interviewed Singtel's group chief financial officer Arthur Lang to discuss the company's recent momentum. Lang noted that profit growth in FY2025 was driven by strong execution across core business units, with subsidiaries Optus and NCS achieving earnings before interest and taxes expansion of 55 per cent and 39 per cent, respectively. He also highlighted the 'Singtel28' strategy's focus on lifting business performance by strengthening the company's core connectivity businesses, and scaling growth areas such as IT services and digital infrastructure. For instance, its data centre arm, Nxera, is expanding rapidly with support from a partnership with KKR, enabling regional growth with partial funding from external capital. Lang also highlighted that longstanding regional partnerships and active capital management to fund growth and boost shareholder returns continue to position Singtel for long-term resilience. Share buybacks In the four sessions, 15 primary-listed companies made buybacks with a total consideration of S$61.8 million. DBS, UOB and OCBC again led the consideration tally, collectively buying back S$58.9 million of shares. On their current buyback mandates, UOB has bought back 0.35 per cent of its outstanding shares, DBS has repurchased 0.22 per cent, and OCBC has bought back 0.06 per cent, as at Jun 18. Secondary-listed Hongkong Land also continued to conduct share repurchases over the four sessions. Director transactions The four trading sessions saw a bit of a pause in director interests and substantial shareholdings filings. There were fewer than 40 filings for 20 primary-listed stocks. Directors or chief executive officers filed six acquisitions and two disposals, while substantial shareholders filed one acquisition and two disposals. These included director or CEO acquisitions in CosmoSteel , Hyphens Pharma International , Mencast and SunMoon Food Company . CosmoSteel On Jun 13, CosmoSteel executive director and CEO Jack Ong acquired two million shares at an average price of S$0.22 each, boosting his direct interest from 17.39 per cent to 18.15 per cent. On May 15, Evolve Capital Advisory, on behalf of 3HA Capital, announced a voluntary conditional cash offer for all issued and paid-up ordinary shares of CosmoSteel at S$0.20 apiece. The offer has drawn scrutiny from significant shareholders the Ong family, who have requested clarifications. Prior to the development, CosmoSteel's CEO had also raised his direct interest from 14.5 per cent. SunMoon Food Company Between Jun 13 and 18, SunMoon Food Company executive director and CEO Zhang Ye acquired 3,099,100 shares at S$0.16 apiece. This increased his total interest from 51.77 per cent to 52.12 per cent. He has been gradually increasing his total interest from 51.57 per cent May 27, when the group reported its FY2024/2025 (ended Mar 31) results. He was appointed CEO and executive director in December 2018. The serial entrepreneur also founded Yiguo – China's first fresh food e-commerce platform – and Enmore Group, which is now a leading player in China's bulk chemical services sector. For FY2024/2025, SunMoon Food Company reported revenue of S$33.83 million, up from S$27.06 million the previous year. The growth was driven by stronger sales of fruits, aquatic foods, and non-hazardous chemical products. The group generated 93 per cent of its revenue for the period from China, with the remainder coming from Asean. Its gross profit for FY2024/2025 remained steady at S$821,000, though the margin declined to 2.43 per cent from 3.03 per cent in FY2023/2024, due mainly to the clearance of slow-moving inventory sold at minimal or negative margins. The company said it is working to enhance profitability by expanding its non-hazardous chemical segment through strategic partnerships. It also remains focused on growing cross-border trade – exporting food products from China to South-east Asia, and importing basa fish (a freshwater fish native to South-east Asia) into China. Hyphens Pharma International On Jun 16, Hyphens Pharma International non-executive director Tan Kia King acquired 33,600 shares at S$0.30 apiece. This grew his total interest incrementally, from 28.13 per cent to 28.14 per cent. The open market purchase followed his acquisitions of 100,000 shares in May and 88,000 shares in April, with both transactions at S$0.285 per share. Appointed in December 2017, Dr Tan brings more than 30 years of medical and leadership experience to the group, including roles as managing director of Westpoint Family Hospital and chairman of Taka Jewellery. Hyphens Pharma International is headquartered in Singapore with direct operations in Indonesia, Malaysia, the Philippines and Vietnam. Its foundation dates back to 1998, when current chairman and CEO Lim See Wah invested in Pan-Malayan Pharmaceuticals, laying the groundwork for a regional healthcare platform. Established in the 1940s, Pan-Malayan is Singapore's oldest pharmaceutical wholesaler, with a rich history of supplying clinics, pharmacies, hospitals, nursing homes and trade partners. In 2002, Lim bought into Hyphens Pharma. The move unlocked Asean expansion and proprietary innovation, including the launch of Ceradan – a therapeutic skincare brand – and strategic research and development with the Agency for Science, Technology and Research. Hyphens Pharma International listed on the SGX Catalist in 2018. With a growing regional footprint, it continues to champion Asia's role in healthcare innovation. The group currently comprises five key entities: Hyphens Pharma, DocMed Technology, Ocean Health, Novem and Ardence Pharma. They advance the three core segments of speciality pharmaceuticals; proprietary brands; as well as medical hypermart and digital. In FY2024 (ended Dec 31), the group reported record revenue of S$195.4 million and a net profit after tax of S$10.9 million. It remains focused on scaling its core segments, with proprietary brands expanding regionally and speciality pharmaceuticals advancing through new launches and exclusive rights. It also continues to strategically enhance longstanding assets such as Pan-Malayan and online marketplace POM, with a focus on building high-traffic digital platforms to unlock greater value. Part of DocMed Technology, POM is a business-to-business pharmaceutical marketplace that operates in Singapore, Malaysia and Vietnam. Hyphens Pharma International maintains a market capitalisation of nearly S$100 million, with a return on equity ratio of 15.2 per cent, dividend yield of 4.8 per cent, and price-to-earnings ratio of 9.6 times as at last week. The counter is also among the 10 SGX-listed healthcare stocks that have booked the highest net institutional inflows in the first half of 2025. In April, Evolve Capital initiated coverage on Hyphens Pharma International with a target price of S$0.365. The advisory platform noted that despite its smaller scale, Hyphens Pharma International maintains decent margins, a net cash position, and consistent revenue growth, making its low valuation unjustified. While near-term growth may moderate, Evolve Capital expects continued portfolio expansion across the segments of speciality pharmaceuticals and proprietary brands. Buybacks and director transactions for Jun 19 will be included next week. The writer is the market strategist at SGX. To read SGX's market research reports, visit
Business Times
3 days ago
- Business Times
Hong Kong developer sells HK$538 million luxury mansion at a loss
HONG Kong developer Chuang's Consortium International is selling a luxury mansion in the upscale Deep Water Bay area at an almost 20 per cent discount, as it seeks cash in a fragile property market. The house at 37 Island Road is being sold to Annex W Group, a British Virgin Islands vehicle owned by Wu Jingtao, for no more than HK$538 million (S$11.6 million), according to a filing to the Hong Kong stock exchange late on Thursday. Chuang's Consortium will record a loss of HK$143.2 million, mainly due to accounting treatment based on the market valuation rather than the cost of development, it said in the filing. The sale would become the third-largest transaction for a new home in Hong Kong this year, after a HK$1 billion villa in the Mont Verra project and a HK$609 million penthouse at Mount Nicholson, according to property database EPRC. Chuang's said the main reasons for the sale included a need to improve the group's liquidity, uncertainty in the Hong Kong property market and the global political environment, and thin transaction volumes for luxury property, according to the filing. The developer, which specialises in high-end projects, is known for selling a mansion to mainland Chinese tycoon Chen Hongtian for more than HK$2 billion in 2016. The house was seized after Chen defaulted on a loan, and was recently on the market for 60 per cent lower than its purchase price. BLOOMBERG
Straits Times
3 days ago
- Straits Times
DBS expects economic value from its use of AI to exceed $1 billion in 2025
Since DBS began focusing on AI, the bank has created more than 350 use cases and has 1,500 models in production PHOTO: ST FILE DBS expects economic value from its use of AI to exceed $1 billion in 2025 SINGAPORE - Banks are ramping up their use of artificial intelligence (AI), and DBS – which has earned $750 million through its use of the technology – estimates that its economic value could surpass $1 billion in 2025. Since the bank began focusing on AI, it has created more than 350 use cases and has 1,500 models in production, said Rajeev Hassamal, DBS' head of generative AI and flow of work, at SuperAI Singapore, a two-day conference held at Sands Expo and Convention Centre. The conference participants at the event discussed, however, the challenges in striking a balance between innovation and responsible use of AI when developing AI models. 'Finding that sweet spot is very hard,' said Mr Hassamal. Speaking at a panel discussion on the integration between AI and finance, he emphasised the importance of equipping employees, regardless of role, with an understanding of how the technology works. 'We need to ensure people understand how to use this technology,' said Mr Hassamal, who showcased DBS' internal generative AI chatbot, DBS-GPT, which helps its employees with content generation and writing tasks, all within a secure environment. Speaking at a separate panel, Sambit Sahu, vice-president of applied research at Capital One, noted that the AI and machine-learning space has completely changed over the past five years. Large language models have progressed from doing simple tasks, to taking a more agentic approach, he noted. One use case of AI, he suggested, is in mimicking employees' tasks, but it does it more efficiently. '(Banks) deal with huge amounts of data, text, images, audio and also visuals,' he added. Sigrid Rouam, chief AI officer at EFG Bank, pointed out that generative AI can also be put to work on compliance-related tasks, such as checking the source of money from a bank's clients. AI can also assist with non-advisory related tasks – those that take up 70 per cent of relationship managers' time, she said. 'All of this should be completely automated and streamlined.' The Monetary Authority of Singapore (MAS) warned that guardrails need to be in place amid the race to implement AI in the financial sector. Kenneth Gay, MAS' chief fintech officer, said that the central bank takes regulation very seriously, given that the regard for regulation is a competitive advantage for Singapore. Project MindForge, an initiative by MAS in 2023, examined the risks and opportunities of generative AI for banks. Mr Gay said that since financial institutions are at the stage of building and deploying generative AI applications, they are seeking more clarity from the government about the sort of specific features that should be included. He added that MAS intends to release a playbook this year that will give institutions from across the segments of the financial sectors, including banking and insurance, more clarity regarding the key risk considerations across AI's key use cases. THE BUSINESS TIMES Join ST's Telegram channel and get the latest breaking news delivered to you.
